A61K 38/06
Tripeptides
A61K38/06 (Tripeptides) appears on 1,462 US grants and 2,487 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,462
- Published applications
- 2,487
- Assignees
- 1,077
- Inventors
- 3,968
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 8 | 0 |
| 1991 | 0 | 0 |
| 1992 | 8 | 0 |
| 1993 | 6 | 0 |
| 1994 | 6 | 0 |
| 1995 | 12 | 0 |
| 1996 | 13 | 0 |
| 1997 | 12 | 0 |
| 1998 | 28 | 0 |
| 1999 | 27 | 0 |
| 2000 | 25 | 0 |
| 2001 | 30 | 9 |
| 2002 | 32 | 40 |
| 2003 | 19 | 60 |
| 2004 | 19 | 69 |
| 2005 | 24 | 75 |
| 2006 | 27 | 75 |
| 2007 | 24 | 86 |
| 2008 | 28 | 64 |
| 2009 | 25 | 71 |
| 2010 | 32 | 73 |
| 2011 | 32 | 71 |
| 2012 | 32 | 75 |
| 2013 | 49 | 96 |
| 2014 | 61 | 173 |
| 2015 | 76 | 130 |
| 2016 | 109 | 181 |
| 2017 | 89 | 154 |
| 2018 | 112 | 140 |
| 2019 | 84 | 127 |
| 2020 | 79 | 128 |
| 2021 | 57 | 105 |
| 2022 | 78 | 110 |
| 2023 | 50 | 131 |
| 2024 | 52 | 96 |
| 2025 | 46 | 86 |
| 2026 | 31 | 62 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Nootropic fullerenes and use22 Sep 2026US 12,741,033 B2Carbon 60 (Zhejiang) Pharmaceutical Technology Co., Ltd.
- Methods and kits for preparing pathogen-inactivated whole blood8 Sep 2026US 12,728,186 B2Cerus Corporation
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Compositions and methods for treating granulomatosis with polyangiitis11 Aug 2026US 12,702,701 B2Canem Holdings, LLC
- Methods and compositions for treating mucosal tissue disorders21 Jul 2026US 12,685,755 B2The University of North Carolina at Chapel Hill
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306431 A1Geneiii Biotech Company Ltd.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Compositions and methods for reducing blood ethanol concentration through alcohol dehydrogenase and acetaldehyde scavengers8 Oct 2026US 2026/0306589 A1Goa Therapeutics Corporation
- Methods of enhancing antibody therapies8 Oct 2026US 2026/0308270 A1Ohio State Innovation Foundation
- Composition for use in prevention and/or treatment of human transthyretin amyloidosis17 Sep 2026US 2026/0272870 A1
Most cited
By later US patents
- Retrograde tissue splitter and method1,605US 5,449,355 AValleylab, Inc. · 1995
- Retrograde tissue splitter and method1,585US 5,797,906 AValleylab, Inc. · 1998
- Intra-oral antioxidant preparations147US 5,906,811 AThione International, Inc. · 1999
- Methods related to the treatment of neurodegenerative and inflammatory conditions135US 8,796,302 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2014
- Prolonged release microcapsules128US 5,480,656 ATakeda Chemical Industries, Ltd. · 1996